ProCE Banner Activity

Changing TKIs Due To Intolerance: Second-Line Therapy and Toxicity Management

Slideset Download
Downloadable slides with expert analysis of CML management after TKI inhibitor intolerance.

Released: June 17, 2020

Expiration: June 16, 2021

Share

Faculty

Carlo Gambacorti-Passerini

Carlo Gambacorti-Passerini, MD

Professor, Hematology
University Milano Bicocca
Director, Hematology
San Gerardo Hospital
Monza, Italy

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.

Faculty Disclosure

Primary Author

Carlo Gambacorti-Passerini, MD

Professor, Hematology
University Milano Bicocca
Director, Hematology
San Gerardo Hospital
Monza, Italy